Daily Intake of Trehalose Is Effective in the Prevention of Lifestyle-Related Diseases in Individuals with Risk Factors for Metabolic Syndrome
Tóm tắt
Từ khóa
Tài liệu tham khảo
1) Elbein AD, Pan YT, Pastuszak I, Carroll D. 2003. New insights on trehalose: a multifunctional molecule. Glycobiology 13: 17R-27R.
2) Arai C, Arai N, Mizote A, Kohno K, Iwaki K, Hanaya T, Arai S, Ushio S, Fukuda S. 2010. Trehalose prevents adipocyte hypertrophy and mitigates insulin resistance. Nutr Res 30: 840-848.
3) Arai C, Miyake M, Matsumoto Y, Mizote A, Yoshizane C, Hanaya Y, Koide K, Yamada M, Hanaya T, Arai S, Fukuda S. 2013. Trehalose prevents adipocyte hypertrophy and mitigates insulin resistance in mice with established obesity. J Nutr Sci Vitaminol 59: 393-401.
4) Arai C, Yoshizane C, Koide K, Mizote A, Arai N, Hanaya T, Arai S, Fukuda S. 2013. Trehalose protects Islets of Langerhans in HFD-fed obese mice: A morphometric analysis. Nippon Eiyou Shokuryo Gakkaishi (J Jpn Soc Nutr Food Sci) 66: 17-24 (in Japanese).
5) Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodés-Cabau J, Bertrand OF, Poirier P. 2008. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 28: 1039-1349.
6) Kim JI, Huh JY, Sohn JH, Choe SS, Lee YS, Lim CY, Jo A, Park SB, Han W, Kim JB. 2015. Lipid-overloaded enlarged adipocytes provoke insulin resistance independent of inflammation. Mol Cell Biol 35: 1686-1699.
7) Veilleux A, Caron-Jobin M, Noël S, Laberge PY, Tchernof A. 2011. Visceral adipocyte hypertrophy is associated with dyslipidemia independent of body composition and fat distribution in women. Diabetes 60: 1504-1511.
8) Jung UJ, Choi MS. 2014. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci 15: 6184-6223.
9) Matsuda M, DeFronzo RA. 1999. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462-1470.
10) DeFronzo RA, Matsuda M. 2010. Reduced time points to calculate the composite index. Diabetes Care 33: e93.
11) Browning LM, Mugridge O, Chatfield MD, Dixon AK, Aitken SW, Joubert I, Prentice AM, Jebb SA. 2010. Validity of a new abdominal bioelectrical impedance device to measure abdominal and visceral fat: comparison with MRI. Obesity (Silver Spring) 18: 2385-2391.
12) Oku T, Nakamura S. 2000. Estimation of intestinal trehalase activity from a laxative threshold of trehalose and lactulose on healthy female subjects. Eur J Clin Nutr 54: 783-788.
13) DiAngelo JR, Birnbaum MJ. 2009. Regulation of fat cell mass by insulin in Drosophila melanogaster. Mol Cell Biol 29: 6341-6352.
14) Kokta TA, Strat AL, Papasani MR, Szasz JI, Dodson MV, Hill RA. 2008. Regulation of lipid accumulation in 3T3-L1 cells: insulin-independent and combined effects of fatty acids and insulin. Animal 2: 92-99.
15) Oka R, Yagi K, Sakurai M, Nakamura K, Nagasawa SY, Miyamoto S, Nohara A, Kawashiri MA, Hayashi K, Takeda Y, Yamagishi M. 2012. Impact of visceral adipose tissue and subcutaneous adipose tissue on insulin resistance in middle-aged Japanese. J Atheroscler Thromb 19: 814-822.
16) Higashiyama T. 2002. Novel functions and applications of trehalose. Pure Appl Chem 74: 1263-1269.
17) Ohtake S, Wang YJ. 2011. Trehalose: current use and future applications. J Pharm Sci 100: 2020-2053.
19) McIntosh CH, Widenmaier S, Kim SJ. 2009. Glucose-dependent insulinotropic polypeptide (Gastric Inhibitory Polypeptide; GIP). Vitam Horm 80: 409-471.
20) Getty-Kaushik L, Song DH, Boylan MO, Corkey BE, Wolfe MM. 2006. Glucose-dependent insulinotropic polypeptide modulates adipocyte lipolysis and reesterification. Obesity (Silver Spring) 14: 1124-1131.
21) Arai N, Yoshizane C, Arai C, Hanaya T, Arai S, Ikeda M, Kurimoto M. 2002. Trehalose ingestion modifies mucosal immune responses of the small intestine in mice. J Health Sci 48: 282-287.
22) Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA, Maza O, Israeli D, Zmora N, Gilad S, Weinberger A, Kuperman Y, Harmelin A, Kolodkin-Gal I, Shapiro H, Halpern Z, Segal E, Elinav E. 2014. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 514: 181-186.